These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16786139)

  • 1. PEA3 cooperates with c-Jun in regulation of HER2/neu transcription.
    Matsui K; Sugimori K; Motomura H; Ejiri N; Tsukada K; Kitajima I
    Oncol Rep; 2006 Jul; 16(1):153-8. PubMed ID: 16786139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PEA3 Ets transcription factor is a downstream target of the HER2/Neu receptor tyrosine kinase.
    O'Hagan RC; Hassell JA
    Oncogene; 1998 Jan; 16(3):301-10. PubMed ID: 9467955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer.
    Benz CC; O'Hagan RC; Richter B; Scott GK; Chang CH; Xiong X; Chew K; Ljung BM; Edgerton S; Thor A; Hassell JA
    Oncogene; 1997 Sep; 15(13):1513-25. PubMed ID: 9380403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genomic explanation connecting "Mediterranean diet", olive oil and cancer: oleic acid, the main monounsaturated fatty acid of olive oil, induces formation of inhibitory "PEA3 transcription factor-PEA3 DNA binding site" complexes at the Her-2/neu (erbB-2) oncogene promoter in breast, ovarian and stomach cancer cells.
    Menendez JA; Papadimitropoulou A; Vellon L; Lupu R
    Eur J Cancer; 2006 Oct; 42(15):2425-32. PubMed ID: 16406575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells.
    Briggs J; Chamboredon S; Castellazzi M; Kerry JA; Bos TJ
    Oncogene; 2002 Oct; 21(46):7077-91. PubMed ID: 12370830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.
    Menendez JA; Vellon L; Lupu R
    Ann Oncol; 2005 Aug; 16(8):1253-67. PubMed ID: 15870086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells.
    Hsu MC; Chang HC; Hung WC
    Endocr Relat Cancer; 2007 Sep; 14(3):655-67. PubMed ID: 17914096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antagonistic regulation of human MUC4 and ErbB-2 genes by the Ets protein PEA3 in pancreatic cancer cells: implications for the proliferation/differentiation balance in the cells.
    Fauquette V; Perrais M; Cerulis S; Jonckheere N; Ducourouble MP; Aubert JP; Pigny P; Van Seuningen I
    Biochem J; 2005 Feb; 386(Pt 1):35-45. PubMed ID: 15461591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the WT1 tumor suppressor gene promoter by Pea3.
    Discenza MT; Vaz D; Hassell JA; Pelletier J
    FEBS Lett; 2004 Feb; 560(1-3):183-91. PubMed ID: 14988020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis.
    Xing X; Wang SC; Xia W; Zou Y; Shao R; Kwong KY; Yu Z; Zhang S; Miller S; Huang L; Hung MC
    Nat Med; 2000 Feb; 6(2):189-95. PubMed ID: 10655108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptidoglycan enhances transcriptional expression of CCAAT/enhancer-binding protein delta gene in mouse macrophages.
    Huang YC; Chang WC; Su JG; Cai JL; Chen CC; Hung JJ; Liu YW
    J Biomed Sci; 2007 May; 14(3):407-18. PubMed ID: 17273900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEA3 transactivates vimentin promoter in mammary epithelial and tumor cells.
    Chen JH; Vercamer C; Li Z; Paulin D; Vandenbunder B; Stehelin D
    Oncogene; 1996 Oct; 13(8):1667-75. PubMed ID: 8895512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ets gene PEA3 cooperates with beta-catenin-Lef-1 and c-Jun in regulation of osteopontin transcription.
    El-Tanani M; Platt-Higgins A; Rudland PS; Campbell FC
    J Biol Chem; 2004 May; 279(20):20794-806. PubMed ID: 14990565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the rat CYP4A2 gene promoter by c-Jun and octamer binding protein-1.
    Fiala-Beer E; Lee AC; Murray M
    Int J Biochem Cell Biol; 2007; 39(6):1235-47. PubMed ID: 17481938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Jun has multiple enhancing activities in the novel cross talk between the androgen receptor and Ets variant gene 1 in prostate cancer.
    Cai C; Hsieh CL; Shemshedini L
    Mol Cancer Res; 2007 Jul; 5(7):725-35. PubMed ID: 17634427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recruitment of nuclear factor Y to the inverted CCAAT element (ICE) by c-Jun and E1A stimulates basal transcription of the bone sialoprotein gene in osteosarcoma cells.
    Su M; Bansal AK; Mantovani R; Sodek J
    J Biol Chem; 2005 Nov; 280(46):38365-75. PubMed ID: 16087680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic activation of the tumor suppressor, HLJ1, by the transcription factors YY1 and activator protein 1.
    Wang CC; Tsai MF; Dai TH; Hong TM; Chan WK; Chen JJ; Yang PC
    Cancer Res; 2007 May; 67(10):4816-26. PubMed ID: 17510411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A positive role for PEA3 in HER2-mediated breast tumour progression.
    Myers E; Hill AD; Kelly G; McDermott EW; O'Higgins NJ; Young LS
    Br J Cancer; 2006 Nov; 95(10):1404-9. PubMed ID: 17060941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human manganese superoxide dismutase suppresses HER2/neu-mediated breast cancer malignancy.
    Chuang TC; Liu JY; Lin CT; Tang YT; Yeh MH; Chang SC; Li JW; Kao MC
    FEBS Lett; 2007 Sep; 581(23):4443-9. PubMed ID: 17719580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of urokinase-type plasminogen activator expression by the HER2/neu proto-oncogene.
    Gum R; Wang SW; Lengyel E; Yu D; Hung MC; Juarez J; Boyd D
    Anticancer Res; 1995; 15(4):1167-72. PubMed ID: 7653995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.